Abstract
Purpose
To evaluate the efficacy of iliac artery stent placement for relief of claudication in patients with both iliac and superficial femoral artery (SFA) lesions.
Methods
Stent placement for only iliac artery occlusive disease was performed in 94 limbs (74 patients) with both iliac and SFA occlusive disease on the same limb. All procedures were performed because intermittent claudication did not improve after continuation of antiplatelet medication therapy and home-based exercise for 3 months. Rutherford classification was 2 in 20 limbs and 3 in 74 limbs. Patients with critical limb ischemia were excluded. Median duration of follow-up was 40 months. Primary patency rates of the iliac stent, clinical improvement rates, and risk factors for requiring additional SFA procedures were evaluated.
Results
Primary patency rates of the iliac stent at 1, 3, 5, and 7 years were 97, 93, 79, and 79 %, respectively. The initial clinical improvement rate was 87 %. Continued clinical improvement rates at 1, 3, 5, and 7 years were 87, 81, 69, and 66 %, respectively. SFA Trans-Atlantic Inter-Society Consensus (TASC) II C/D lesion was a significant risk factor for requiring additional SFA procedures.
Conclusion
Intermittent claudication was relieved by iliac stent placement in most patients with both iliac and SFA lesions. Thus, the indications for treatment of the SFA intended for claudicants should be evaluated after treatment of the iliac lesion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Norgren L, Hiatt WR, Dormandy JA et al (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33:S1–S70
Balzer JO, Thalhammer A, Khan V et al (2010) Angioplasty of the pelvic and femoral arteries in PAOD: results and review of the literature. Eur J Radiol 75:48–56
Ichihashi S, Higashiura W, Itoh H et al (2011) Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II. J Vasc Surg 53:992–999
Koizumi A, Kumakura H, Kanai H et al (2009) Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions. Circ J 73:860–866
Ihnat DM, Duong ST, Taylor ZC et al (2008) Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score. J Vasc Surg 47:967–974
Dearing DD, Patel KR, Compoginis JM et al (2009) Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg 50:542–548
Soga Y, Iida O, Hirano K et al (2010) Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg 52:608–615
Kamiya C, Sakamoto S, Tamori Y et al (2008) Long-term outcome after percutaneous peripheral intervention vs medical treatment for patients with superficial femoral artery occlusive disease. Circ J 72:734–739
Faries PL, Brophy D, LoGerfo FW et al (2001) Combined iliac angioplasty and infrainguinal revascularization surgery are effective in diabetic patients with multilevel arterial disease. Ann Vasc Surg 15:67–72
Timaran CH, Ohki T, Gargiulo NJ et al (2003) Iliac artery stenting in patients with poor distal runoff: influence of concomitant infrainguinal arterial reconstruction. J Vasc Surg 38:479–485
Rutherford RB, Baker JD, Ernst C et al (1997) Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26:517–538
Kudo T, Rigberg DA, Reil TD et al (2006) The influence of the ipsilateral superficial femoral artery on iliac angioplasty. Ann Vasc Surg 20:502–511
Prendiville EJ, Burke PE, Colgan MP et al (1992) The profunda femoris: a durable outflow vessel in aortofemoral surgery. J Vasc Surg 16:23–29
Pearce WH, Kempczinski RF (1984) Extended autogenous profundaplasty and aortofemoral grafting: an alternative to synchronous distal bypass. J Vasc Surg 1:455–458
Chetter IC, Spark JI, Kent PJ et al (1998) Percutaneous transluminal angioplasty for intermittent claudication: evidence on which to base the medicine. Eur J Vasc Endovasc Surg 16:477–484
Dick P, Mlekusch W, Sabeti S et al (2006) Outcome after endovascular treatment of deep femoral artery stenosis: results in a consecutive patient series and systematic review of the literature. J Endovasc Ther 13:221–228
Murphy TP, Cutlip DE, Regensteiner JG et al (2012) Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication. Exercise Versus Endoluminal Revascularization (CLEVER) study. Circulation 125:130–139
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ichihashi, S., Higashiura, W., Itoh, H. et al. Iliac Artery Stent Placement Relieves Claudication in Patients with Iliac and Superficial Femoral Artery Lesions. Cardiovasc Intervent Radiol 36, 623–628 (2013). https://doi.org/10.1007/s00270-012-0427-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-012-0427-8